Characteristics | Mabat Zahav 1 N = 1647 n (%) | Mabat Zahav 2 N = 833 n (%) | P* |
---|---|---|---|
Sex | 0.85 | ||
Males | 748 (45.4) | 375 (45.0) | |
Females | 899 (54.6) | 458 (55.0) | |
Age group, years | 0.62 | ||
65–79 | 1284 (78.0) | 642 (77.1) | |
≥ 80 | 363 (22.0) | 191 (22.9) | |
Education, years | <0.0001 | ||
0–8 years | 540 (32.9) | 206 (25.4) | |
9–12 years | 528 (32.1) | 230 (28.4) | |
≥ 13 not academic | 247 (15.0) | 126 (15.6) | |
≥ 13 academic | 328 (20.0) | 248 (30.6) | |
Population group | <0.001 | ||
Jews | 1384 (84.0) | 743 (89.2) | |
Arabs | 263 (16.0) | 90 (10.8) | |
Socioeconomic status | <0.001 | ||
Above poverty line | 947 (73.6) | 526 (80.9) | |
Below poverty line | 339 (26.4) | 124 (19.1) | |
Subjective Health status | <0.001 | ||
Good | 878 (53.3) | 383 (46.3) | |
Poor | 769 (46.7) | 445 (53.7) | |
Comorbidity | 0.14 | ||
No chronic illness | 156 (9.6) | 97 (11.7) | |
1–3 chronic illnesses | 1248 (76.5) | 635 (76.3) | |
≥ 4 chronic illnesses | 228 (14.0) | 100 (12.0) | |
Polypharmacy | < .0001 | ||
(< 5 drugs/d) | 589 (35.8) | 364 (43.7) | |
(≥ 5 drugs/d) | 1058 (64.2) | 469 (56.3) | |
Major polypharmacy | < .0001 | ||
(< 8 drugs/d) | 1154 (70.1) | 644 (77.3) | |
(≥ 8 drugs/d) | 493 (29.9) | 189 (22.7) |